Insider trade

Officer sold ~$505K of HIMS shares in the open market

Traded Dec 17, 2025 · Filed Dec 18, 2025

Why it stands out

Hims & Hers Health's Chief Operating Officer sold $505K of Hims & Hers Health shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$504,763

Shares × reported transaction price

Timing vs results

44 days after results of Nov 3, 2025, 68 days before results of Feb 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−3.5%	+1.4%	−5.0%
30 days	−14.3%	−0.4%	−13.9%
90 days	−32.1%	−3.0%	−29.0%
180 days	−10.3%	+8.9%	−19.2%

Past results only. Not a forecast.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

9mo ago

Derivative exercise or conversion — not an open-market buy.

9mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance9mo ago